Posted on 7/19/20
Karyopharm Establishes Partnership with National Cancer Institute
NEWTON, Mass., July 17, 2020 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an innovation-driven pharmaceutical company, today announced that it has entered into a Cooperative Research . . .
Posted on 7/18/20
Relay Therapeutics Prices IPO
CAMBRIDGE, Mass., July 15, 2020 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by leveraging unparalleled . . .
Posted on 7/17/20
Ambu Receives FDA Clearance for its Sterile, Single-use Duodenoscope
Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, announced today that the Ambu® aScope™ Duodeno has received 510(k) clearance from . . .
Posted on 7/17/20
Mauna Kea Technologies Secures €4M of Non-Dilutive Loans
PARIS & BOSTON--(BUSINESS WIRE)--Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, announced that it . . .
Posted on 7/16/20
Tegra Medical Announces Major Expansions in Massachusetts and Mississippi
Continuing a steady path of growth in the medical device manufacturing industry, Tegra Medical announced today the purchase of an additional building across the street from . . .
Posted on 7/16/20
Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of . . .
Posted on 7/16/20
Oncorus Announces Clinical Trial Collaboration with Merck
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oncorus Announces Clinical Trial Collaboration with Merck to Evaluate the Combination of Oncorus’ ONCR-177 with Merck’s KEYTRUDA® (pembrolizumab) in Adult Patients with Advanced and/or . . .
Posted on 7/16/20
Twist Bioscience Partners with Invetx
SOUTH SAN FRANCISCO, Calif. & BOSTON, Mass.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using . . .
Posted on 7/16/20
Adagio Therapeutics Launches With $50M Series A Financing
Adagio Therapeutics, Inc., today launched with the closing of a $50 million Series A financing, to advance its portfolio of coronavirus antibodies as both therapeutics and . . .
Posted on 7/16/20
Kronos Bio and Gilead Sciences Enter Into Asset Purchase Agreement for Gilead's SYK Inhibitor Portfolio
SAN MATEO, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Kronos Bio, Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform . . .
Posted on 7/16/20
F-star Therapeutics: Merck KGaA, Darmstadt, Germany Takes an Early Option in Immuno-Oncology Collaboration
CAMBRIDGE, England & CAMBRIDGE, Mass.--(BUSINESS WIRE)--F-star Therapeutics Ltd., a clinical-stage biopharmaceutical company focused on transforming the lives of patients with cancer through the development of innovative . . .
Posted on 7/16/20
Cohere Health Raises $10MM In Series A
Cohere Health has announced its company launch, with the mission of aligning the relationship between physicians and health plans around the care journey in a way . . .
Posted on 7/16/20
Better Coronavirus Vaccine Stock: BioNTech vs. Moderna
There are now 23 coronavirus vaccine candidates in clinical testing, according to the World Health Organization. Four of them use an approach that involves engineering messenger . . .
Posted on 7/16/20
Is Boston Scientific Stock a Buy?
There's a lot to appreciate about Boston Scientific Corporation (NYSE:BSX) from a healthcare investor's point of view. Beyond the company's massive line of specialist tools for . . .
Posted on 7/16/20
Could Moderna's Coronavirus Vaccine Be a $5 Billion Opportunity?
Despite concerted efforts to curb the spread of COVID-19, new cases of the disease continue to pop up at an alarming rate in several states. As . . .
Posted on 7/16/20
Better Buy: Moderna vs. BioCryst Pharmaceuticals
BioCryst Pharmaceuticals (NASDAQ:BCRX) and Moderna (NASDAQ:MRNA) are both biotech companies developing products to combat the COVID-19 pandemic, but the similarities end there. Each company has a . . .
Posted on 7/15/20
Tufts Health Plan Named a Best Place to Work for Disability Inclusion
Tufts Health Plan has been recognized as a Best Place to Work by Disability:IN and the American Association of People with Disabilities (AAPD) on its 2020 . . .
Posted on 7/15/20
The Meadows Health Center at Edgewood Named Best Nursing Home For Sixth Time
The Meadows Health Center, the skilled nursing neighborhood at Edgewood Retirement Community in North Andover, MA, was named a Best Nursing Home by U.S. News & . . .
Posted on 7/15/20
Rite Aid Expands COVID-19 Testing to 258 Total Locations
CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) will continue to expand its COVID-19 testing capacity with the addition of 161 drive-through testing locations opening on July . . .
Posted on 7/15/20
Arrakis Therapeutics Appoints Erik Spek, Ph.D., J.D., as VP of Legal and Intellectual Property
Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines
Posted on 7/15/20
Berkshire Hathaway Purchases Dominion Energy Assets - Building An Energy Business
SummaryBerkshire Hathaway recently made a massive $10 billion purchase of Dominion Energy natural gas assets, adding to a growing energy portfolio.In a market where value is . . .
Posted on 7/15/20
IPO Update: Pandion Therapeutics Seeks $94 Million IPO
SummaryPandion Therapeutics has filed proposed terms for its IPO.The company is developing treatments for gastrointestinal and liver diseases.PAND is still in Phase 1 safety trials for . . .
Posted on 7/15/20
Verastem: A Growth Story In The Biotechnology Sector
SummaryVerastem trades at a near all-time low, so it's the perfect moment to analyze the risks and rewards of this investment.The company has a strong distribution . . .
Posted on 7/15/20
Blueprint Medicines Inks Deal With Roche Worth Up to $1.7 Billion
Blueprint Medicines (NASDAQ:BPMC) announced Tuesday that global biopharma giant Roche Holdings (OTC:RHHB.Y) is paying up to $1.7 billion in upfront cash and potential milestones, plus royalties, . . .
Posted on 7/14/20
Samantha Meade Joins Peak Physical Therapy & Sports Performance as a Physical Therapy Aide
Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide
Boston
